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Abstract: Acetamidine hydrochloride and p-aminobenzamidine dihydrochloride interact 
with 3-ferrocenylmethylidene-2,4-pentanedione at 80–82 °C in the presence of K2CO3 in 
the water–alcohol medium in two tautomeric forms (the amidoimine and enediamine ones) 
with formation of mixtures of pyrimidine and piperidone derivatives and polymeric 
coordination complexes of potassium ferrocenyl(hexahydro)pyrimidoxides. The structure 
of the resultant compounds is elucidated on the basis of IR, 
1H- and 
13C-NMR 
spectroscopy, mass spectrometry and elemental analysis data. The crystal structures of   
6-ferrocenyl-4-hydroxy-4-methyl-2-piperidone, potassium 6-ferrocenyl-4-methyl-2-
methylidene(hexahydro)pyrimidin-4-oxide  and 2-(4-aminophenyl)-4-ferrocenyl-6-methyl-
pyrimidine were determined by X-ray analysis of suitable single crystals. 
Keywords: ferrocene; 3-ferrocenylmethylidene-2,4-pentanedione; amidines; ferrocenyl-
pyrimidines; ferrocenylpiperidones; complexes of potassium ferrocenyl(hexahydro)-
pyramidin-4-oxides 
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1. Introduction 
Organic compounds of the ferrocene series evoke interest in view of their potential practical 
applications in diverse fields, such as organic and organometallic synthesis, coordination chemistry, 
materials science, homogeneous catalysis, supramolecular chemistry, chemo- and biosensors, 
medicinal chemistry, etc. [1–7]. Ferrocenyl-substituted nitrogen heterocycles are of special interest in 
the search for bioactive substances. Such compounds include ferrocenyl derivatives of pyrazolines, 
pyrazoles, triazoles, benzimidazoles, benzindazoles, quinuclidines, pyrimidines, etc. [8–15]. It is 
known that the presence of ferrocene groups in heterocyclic compounds usually enhances their 
pharmacological characteristics in comparison with substances of similar structure but without 
ferrocene substituents. Therefore, the keen interest in the synthesis of novel ferrocenyl-containing 
heterocycles is quite natural, especially if these compounds contain functional groups in heterocyclic rings.  
We have recently reported the synthesis of ethyl-2-aryl(methyl)- and 2-amino-6-ferroce-
nyl(dihydro)pyrimidine-4-carboxylates with high anticarcinogenic activity [16] via the reaction 
between ethyl-2-acyl-3-ferrocenyl acrylates with amidines. Bioactive ferrocenyl(dihydro)pyrimidines 
with ethoxycarbonyl substituents in the heterocyclic nuclei were isolated with yields about 40%–45%, 
together with the products of several side processes: fragmentations of the initial ethyl 2-acyl-3-
ferrocenyl acrylates, 1,3-insertion of amidines into ferrocenyl acrylates [16–18], etc. However, despite 
the comparatively low yields of ferrocenyl(dihydro)pyrimidines, the high bioactivity of the latter 
compounds evoked our interest in a more detailed investigation of the interaction between ferrocenyl-
containing β-dicarbonyl compounds and nitrogen polynucleophiles. 
2. Results and Discussion 
2.1. Reactions of Acetamidine and p-Aminobenzamidine with 3-Ferrocenylmethylidene-2,4-pentanedione 
This paper investigates the interaction of acetamidine hydrochloride (2) and p-aminobenzamidine 
dihydrochloride (3) with 3-ferrocenylmethylidene-2,4-pentanedione (1) in the presence of excess of 
K2CO3. Acetamidine and p-aminobenzamidine, which are formed from hydrochlorides 2 and 3 as a 
result of treatment with potassium carbonate in the water-alcohol medium used, must exist in two 
tautomeric forms: 2a and 2b, 3a and 3b (Scheme 1), respectively. Thus, 3-ferrocenylmethylidene-2,4-
dione (1) must interact with each of the tautomeric forms 2a, 2b and 3a, 3b of the amidines. 
Scheme 1. Tautomeric forms of the acetamidine (2a, 2b) and p-aminobenzamidine (3a, 3b). 
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Indeed, we have found that 1,3-diketone 1 reacts with acetamidines (2a,b) (water–alcohol medium, 
K2CO3, 80–85 °C), yielding a mixture of several products: 4-ferrocenyl-3-butenone (4, ~25%),   
4-ferrocenyl-2,6-dimethylpyrimidine (5, ~20%), 6-ferrocenyl-4-hydroxy-4-methyl-2-piperidone (6, ~23%), 
and potassium 6-ferrocenyl-4-methyl-2-methylidene(hexahydro)pyrimidin-4-oxide (7, ~17%) (Scheme 2). 
Compounds  4–7 were separated on a chromatographic column containing Al2O3 (Brockmann 
activity grade III). The first compound to leave the column is chalcone 4 (eluent: hexane–ether, 5:1), the 
next one is pyrimidine 5 (eluent: hexane–ether, 2:1), then hydroxypiperidone 6 (eluent: hexane–CH2Cl2, 
2:1), and the last one to be washed out is potassium pyrimidoxide 7 (eluent: CH2Cl–CH3OH–H2O, 2:2:1). 
The structure of compounds 4–7 was elucidated on the basis of elemental analysis, mass 
spectrometry, 
1H and 
13C-NMR spectroscopy data, as well as X-ray diffraction analysis of single 
crystals of compounds 6 and 7. 
Scheme 2. Reaction of 3-ferrocenylmethylidene-2,4-pentanedione (1) with acetamidine (2a,b). 
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According to 
1H-NMR findings, 4-ferrocenyl-3-butenone (4) is generated solely in the form of  
the trans-isomer according to the J = 15.9 Hz spin-spin coupling constant of the olefin protons. The 
1H-NMR spectrum of ferrocenylpyrimidine 5 contains signals from hydrogen atoms of two methyl 
groups and one ferrocene substituent, as well as one singlet from the olefinic hydrogen atom of the 
heterocycle. Additionally, in the 
13C-NMR spectrum of compound 5, there are three signals from the 
C1, C3 and C5 carbons of the heterocyclic ring and one signal from CipsoFc, thus unambiguously 
confirming the structure of the resultant ferrocenylpyrimidine 5. 
The structure of hydroxypiperidone 6 was established on the basis of IR, 
1H-NMR, and 
13C-NMR 
spectroscopy. The IR spectrum of compound 6 contains characteristic absorption bands of the NH, 
OH, C=O, and Fc groups (see the Experimental section). The 
1H-NMR spectrum contains signals from 
protons of one methyl and one ferrocene substituents, one hydroxyl group, one NH-fragment, two 
doublets from protons of the methylene fragment in the heterocycle, and also an ABX pattern of 
signals from protons of the –CH2–CH– fragment in the heterocycle. The 
13C-NMR data also confirm 
the structure of compound 6. 
In addition to spectral data, the spatial configuration of piperidone 6 was further confirmed by  
X-ray diffraction analysis of single crystals obtained by crystallization from CH2Cl2. The general view 
of molecule 6 is shown in Figure 1, while the principal geometric parameters are listed in the Table 1. Molecules 2014, 19  44 
 
The six-membered cycle in structure 6 has a boat conformation, where the ferrocene and methyl 
substituents occupy the axial-equatorial positions. 
Figure 1. X-ray crystal structure of 6. 
 
The structure of product 7, isolated by chromatography with the use of water in the eluent, was 
determined according to the corresponding elemental analysis, mass spectrometry, IR, 
1H-NMR, and  
13C-NMR spectroscopy data. According to these findings, molecule 7 contains the following 
fragments: Me, Fc, CH2=, 2 NH and –CH2–CH–, in addition to two signals of quaternary carbons  
(δ = 55.01, 158.75) and one signal of CipsoFc. 
Compound 7 is a water- and alcohol-soluble yellow crystalline substance, storage-stable in the 
crystalline form and in solutions, it decomposes during melting (~286 °C), a property that is characteristic 
of ionic products. Using crystallization from aqueous methanol, we have managed to grow single crystals 
of 7 that were suitable for X-ray diffraction studies of the spatial structure of 7. The general view of 
molecule 7 is shown in Figure 2, and the main geometrical parameters are listed in Table 1. 
Figure 2. X-ray crystal structure of 7. 
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Table 1. Selected bond lengths and bond angles for compounds 6, 7 and 8. 
Selected bond lengths (Å)  Selected bond angles (°) 
6 
C(11)-N(1) 1.476(3)  N(1)-C(11)-C(12)  111.22(19) 
C(11)-C(12) 1.520(3)  C(13)-C(12)-C(11)  113.77  (18) 
C(12)-C(13) 1.517(3)  O(1)-C(13)-C(12) 111.54(19) 
C(13)-O(1) 1.439(3),  O(1)-C(13)-C(14) 105.81(18) 
C(15)-N(1) 1.329(3) C(12)-C(13)-C(14)  108.05  (19) 
C(13)-C(14) 1.524(3)  C(15)-C(14)-C(13) 112.94(19) 
C(14)-C(15)  1.506(3) O(2)-C(15)-N(1) 121.3(2) 
C(15)-O(2) 1.247(3).  N(1)-C(15)-C(14)  117.9(2) 
7 
N(1)-C(11) 1.482(6) N(1)-C(11)-C(12) 109.6(4) 
C(11)-C(12) 1.522(6) C(13)-C(12)-C(11) 112.7(4) 
C(12)-C(13) 1.520(7)  O(1)-C(13)-N(2)  105.1(4) 
C(13)-O(1) 1.418(6) O(1)-C(13)-C(12) 111.3(4) 
C(13)-N(2) 1.469(6) N(2)-C(13)-C(12) 106.8(4) 
C(14)-N(2) 1.305(6)  N(2)-C(14)-N(1)  120.4(4) 
C(14)-N(1) 1.327(6) N(2)-C(14)-C(15) 120.5(4) 
C(14)-C(15) 1.487(6)  N(1)-C(14)-C(15)  119.1(4) 
O(1)-K(1) 3.072(4) C(13)-O(1)-K(1) 119.5(3) 
K(1)-N(1)#1 3.136(4)  O(1)-K(1)-N(1)#1 97.31(10) 
N(1)-K(1)#1 3.136(4)  O(1)-K(1)-N(2)#2  138.86(11) 
K(1)-N(2)#2 3.147(5) N(1)#1-K(1)-N(2)#2  92.44(11) 
N(2)-K(1)#3 3.147(5)  C(14)-N(2)-C(13)  123.1(4) 
C(13)-C(16))  1.502(7)  C(14)- N(1)- K(1)#1  117.0(3) 
C(1)-Fe(1)  2.044(5)  C(11)- N(1)- K(1)#1  116.9(3) 
N(1)- H(N1)  0.91(5)  C(14)- N(2)- K(1)#3  121.2(3) 
N(2)- H(N2)  0.76(5)  C(13)- N(2)- K(1)#3  115.4(3) 
8 
N(1)-C(11) 1.347(5) N(1)-C(11)-C(12)  121.4(3) 
C(11)-C(12) 1.400(5) C(13)-C(12)-C(11) 116.9(3) 
C(12)-C(13) 1.389(6)  N(2)-C(13)-C(12)  121.8(3) 
C(13)-N(2) 1.347(5) N(2)-C(13)-C(21) 117.5(3) 
C(14)-N(2) 1.340(5)  N(2)-C(14)-N(1)  125.3(3) 
C(14)-N(1) 1.341(5) N(2)-C(13)-C(15) 118.7(3) 
C(14)-C(15) 1.470(5)  C(14)-N(1)-C(11)  117.3(3) 
C(18)-N(3) 1.377(5) C(14)-N(2)-C(13) 117.2(3) 
As follows from the results of this analysis, compound 7 has the structure of potassium   
6-ferrocenyl-4-methyl-2-methylidene(hexahydro)pyrimidin-4-oxide. The central fragment of the 
molecule is a six-membered ring with two nitrogen atoms. A characteristic feature of the crystal 
structure of 7 is that the unit cell contains two molecules with oppositely oriented ferrocene fragments 
and methylene fragments oriented so as to be brought closer to each other (Figure 3). Molecules 2014, 19  46 
 
Figure 3. Structure of the fragment of unit cell of 7. 
 
Figure 4 shows the nature of coordination interactions of the potassium cation with three adjacent 
molecules 7, forming the polymeric structure of compound 7 and determining its high stability. 
Figure 4. Fragment of X-ray crystal structure of 7. 
 
The interaction of 3-ferrocenylmethylidene-2,4-pentanedione (1) with 4-aminobenzamidine (3a,b) 
dihydrochloride (EtOH/H2O, K2CO3, 80–82 °C) also leads to the formation of a mixture of several 
products: trans-4-ferrocenyl-3-butenone (4), 2-(4-aminophenyl)-4-ferrocenyl-6-methylpyrimidine (8), 
and three spiro compounds: 9, 10, and 11 (Scheme 3). 
Compounds 4, 8–11 were separated using column chromatography (Al2O3, grade III). The structure 
of each compound was determined on the basis of IR, 
1H and 
13C-NMR spectra, mass spectra, and 
elemental analysis, which are described in the Experimental section.  
X-ray analysis of single crystals of compound 8 obtained by crystallization from CH2Cl2 confirmed 
the structure of 8 to be that of 2-(4-aminophenyl)-4-ferrocenyl-6-methylpyrimidine (Figure 5). The X-
ray analysis data show that the N-C bonds in pyrimidine 8 have virtually equal lengths [d = 1.347 (5), 
1.340 (5) Å]. The lengths of Fe-C bonds and the geometry of the ferrocene sandwich are the same as in 
related compounds [19]. Molecules 2014, 19  47 
 
Scheme 3. Reaction of 3-ferrocenylmethylidene-2,4-pentanedione (1) with 4-amino- 
benzamidine (3a,b). 
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Figure 5. X-ray crystal structure of 8. 
 
Compounds 9 and 10 are bright red powder substances, isolated in yields of about 10%–12%. The 
IR spectra of compounds 9 and 10 contain the corresponding numbers of characteristic C=O 
(compounds 9 and 10), NH2 and OH (compound 10), and Fc fragment absorption bands. The 
1H-NMR 
spectra of compounds 9 and 10 contain signals from the unsubstituted cyclopentadienyl rings of 
ferrocene, together with signals from protons of substituted cyclopentadienyl rings, signals from 
methyl groups, from olefin protons (compounds 9 and 10), from hydroxyl and amine groups 
(compound 10), and semiquinoid substituents. Each of the 
13C-NMR spectra contains one signal from 
the quaternary spiro carbon atoms with δ = 48.31 ppm and 47.28 ppm, one signal of CipsoFc, and the 
corresponding numbers of signals from carbon atoms of carbonyl groups and quaternary carbons of the 
heterocycles. The mass spectra of compounds 9 and 10 contain peaks of molecular ions with m/z = 371 
and 378 [M]
+, respectively; this fact also confirms the assumed structure. 
Compound 11 is a yellow powder, which is soluble in water, methanol, and DMSO; it decomposes 
upon heating (~310 °C). The mass spectrum of compound 11 contains the peak of a molecular ion with 
m/z = 429 [M]
+. The IR spectrum of compound 11 contains the characteristic absorption bands of the 
Fc, C=O, and NH groups. The 
1H and 
13C-NMR spectroscopy data are provided in the Experimental 
section. As follows from the 
1H-NMR spectra, compound 11 was obtained in the form of one Molecules 2014, 19  48 
 
diastereomer, presumably with a,e-trans-oriented Fc and Me groups. On the basis of our data and by 
analogy with the structure of potassium pyrimidoxide 7, product 11 was assumed to have the structure 
of potassium 6-ferrocenyl-4-methyl-2(4-oxo-2,5-cyclohexadienylidene)-hexahydropyrimid-4-oxide. 
Unfortunately, we failed to obtain single crystals of compound 11 that would be suitable for 
confirming its spatial structure by X-ray diffraction analysis.  
The results of this study (Schemes 2 and 3) show that all heterocyclic compounds 5–7 and 8–11 
were formed via fragmentation of the initial β-diketone into chalcone 4, whose cyclocondensation with 
amidines 2a,b and 3a,b yielded products 5–11. In this process, pyrimidines 5 and 8 were formed from 
tautomers 2a and 3a, and compounds 6, 7, 9–11 were formed from tautomers 2b and 3b, respectively.  
To prove this statement, we studied the interaction of 4-ferrocenyl-3-buten-2-one 1 with amidines 2 
and 3 under similar conditions (EtOH/H2O, K2CO3, 80–82 °C) and found that enone under these 
conditions does not cyclocondense with amidines 2 and 3 (Scheme 4). 
Scheme 4. Reaction of 4-ferrocenyl-3-buten-2-one (1) with amidines (2) and (3). 
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H Fc
H
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The reaction almost quantitatively yielded the initial chalcone 4, even after boiling of the reaction 
mixture for 24 h. 
2.2. Posible Mechanisms of the Reactions of Acetamidine and p-Aminobenzamidine with 3-Ferrocenyl-
methylidene-2,4-pentanedione 
On the basis of the results, we can make the following conclusions:  
(1)   Chalcone 4 is formed in the studied reactions as a result of one-pot nucleophilic attack of 
amidine nitrogens on the carbonyl carbon of the acetyl group in β-diketone 1 (Scheme 5a). 
(2) Compounds 5–11 were formed in the three-component reaction with a simultaneous 
nucleophilic attack of two amidine molecules (2 or 3) on one β-diketone molecule. The 
presumable reaction mechanisms are shown in Schemes 5b and 6a,b. 
Schemes 5. Plausible mechanisms for the formation of compound 4 (a), compounds 5 and 8 (b). 
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Schemes 6. Plausible mechanisms for the formation of compounds 6,  9,  10 ( a),  
compounds 7 and 11 (b). 
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3. Experimental 
3.1. General 
Column chromatography was carried out on alumina (Brockmann activity III). The 
1H- and   
13C-NMR spectra were recorded on a Unity Inova Varian spectrometer (300 and 75 MHz) for solutions 
in CDCl3 (for compounds 4–6 and 8–10) and D2O (for compounds 7 and 11), with Me4Si as the 
internal standard. The IR spectra were measured with a Perkin-Elmer Instruments Spectrum RXI FTIR 
spectrophotometer using KBr pellets. The mass spectra were obtained on a Varian MAT CH-6 
instrument (EI MS, 70 eV). The melting pointa were determined with w micro melting point apparatus 
(Boëtius or Fisher) and the uncorrected values were used. An Elementar Analysensysteme LECO 
CHNS-900 apparatus was used for the elemental analyses. The following reagents were purchased 
from Aldrich (Toluca, Mexico): ferrocenecarbaldehyde, 99%; acetylacetone, 99+%; acetamidine 
hydrochloride, 95%; 4-aminobenzamidine dihydrochloride, 95%. 3-Ferrocenyl-methylidenepentane-
2,4-dione (1) was prepared by condensation of ferrocenecarbaldehyde with acetylacetone in benzene in 
the presence of piperidinium acetate. The physical and 
1H-NMR spectroscopic characteristics of 
compound 1 were all in accordance with the literature data [18,20,21]. 
3.2. Reactions of 3-Ferrocenylmethylidenepentane-2,4-dione (1) with Acetamidine Hydrochloride (2) 
(General Procedure) 
A mixture of compound 1 (1.48 g, 5.0 mmol), acetamidine hydrochloride (2, 0.95 g, 10.0 mmol), 
ethanol (60 mL), H2O (10 mL) and K2CO3 (1.4 g) was stirred for 2 h at 80 °C. The solvents were 
removed in vacuo, the residue mixed with dichloromethane (50 mL) and Al2O3 (activity III) (20 g). 
The solvent was evaporated in air. This sorbent was applied onto a column with Al2O3 (the height of 
alumina is ca. 20 cm) and the reaction products were eluted from the column to afford the following 
reaction products: trans-4-ferrocenyl-3-buten-2-one (4, eluted with hexane–ether, 5:1), 4-ferrocenyl-
2,6-dimethylpyrimidine (5, eluted with hexane–ether, 2:1), 6-ferrocenyl-4-hydroxy-4-methyl-2-piperidone Molecules 2014, 19  50 
 
(6, eluted with hexane–dichloromethane, 2:1), potassium 6-ferrocenyl-4-methyl-2-methyliden-
hexahydro-4-pyrimidoxide (7, eluted with dichloromethane–methanol–water, 2:2:1). 
Trans-4-ferrocenyl-3-buten-2-one (4). Red crystals, yield 0.32 g (25%, from 2), 0.27 g (21 %, from 3), 
m.p. 104–105 °C. 
1H-NMR: 2.28 (s, 3H, CH3), 4.14 (s, 5H, C5H5), 4.14 (s, 5H, C5H5), 4.43 (m, 2H, 
C5H4), 4.50 (m, 2H, C5H4), 6.32 (d, 1H, CH=, J = 15.9 Hz), 7.42 (d, 1H, CH=, J = 15.9 Hz) 
4-Ferrocenyl-2,6-dimethylpyrimidine (5). Orange crystals, yield 0.30 g (20%), m.p. 120–121 °C. IR 
(KBr): 491, 793, 820, 923, 1002, 1061, 1086, 1120, 1181, 1200, 1233, 1232, 1331, 1368, 1472, 1565, 
1642, 1719, 2931, 2934, 2971, 3065, 3018, 3301 cm
−1; 
1H-NMR: 2.47 (s, 3H, CH3), 2.67 (s, 3H, CH3), 
4.18 (s, 5H, C5H5), 4.45 (m, 2H, C5H4), 4.96 (m, 2H, C5H4), 7.01 (s, 1H, CH=); 
13C-NMR: 29.18, 
30.16 (2CH3), 69.58 (C5H5), 69.83, 71.12 (C5H4), 88.75 (CipsoFc), 132.16 (CH=), 143.62, 152.19, 159.85 
(3C). MS: m/z 292 [M]
+. Anal. Calcd. for C16H16FeN2: C 65.78, H 5.52, Fe 19.12, N 9.58. Found: C 65.69, 
H 5.38, Fe 19.23, N 9.68. 
6-Ferrocenyl-4-hydroxy-4-methyl-2-piperidone (6). Yellow crystals, yield 0.36 g (23%), m.p. 147–148 °C. 
IR (KBr): 512, 771, 805, 820, 953, 1002, 1045, 1079, 1103, 1147, 1198, 1223, 1309, 1348, 1376, 
1489, 1571, 1668, 2956, 2980, 3324, 3429 cm
−1; 
1H-NMR: 1.36 (s, 3H, CH3), 1.51 (dd, 1H, CH2,  
J = 11.7, 13.2 Hz), 2.03 (dd, 1H, CH2, J = 4.17, 13.2 Hz), 2.12 (bs, 1H, OH), 2.39 (d, 1H, CH2,  
J = 17.7 Hz), 2.50 (d, 1H, CH2, J = 17.7 Hz), 4.22 (s, 5H, C5H5), 4.15 (m, 1H, C5H4), 4.17 (m, 2H, 
C5H4), 4.21 (m, 1H, C5H4), 4.54 (dd, 1H, CH, J = 4.16, 11.7 Hz), 6.18 (bs, 1H, NH); 
13C-NMR: 30.14 
(CH3), 44.70, 45.17 (2CH2), 64.63 (CH), 68.68 (C5H5), 66.68, 68.25, 68.39, 68.97 (C5H4), 90.54 
(CipsoFc), 49.07, 171.26 (2C); MS: m/z 313 [M]
+. Anal. Calcd. for C16H19FeNO2: C 61.36, H 6.12, Fe 
17.83, N 4.47. Found: C 61.18, H 6.16, Fe 17.79, N 4.58. 
Potassium 6-ferrocenyl-4-methyl-2-methyliden-4-hexahydropyrimidoxide ( 7). Yellow crystals, yield 
0.30 g (17%), m.p. dec.ca 302 °C. IR (KBr): 486, 502, 607, 771, 803, 821, 953, 1004, 1020, 1052, 
1077, 1104, 1152, 1198, 1219, 1306, 1338, 1371, 1480, 1571, 1687, 2950, 2980, 3324 cm
−1; 
1H-NMR 
(D2O): 1.83 (s, 3H, CH3), 2.21 (t, 1H, CH2, J = 13.5 Hz), 2.43 (dd, 1H, CH2, J = 3.9, 13.5 Hz), 4.54 
(dd, 1H, CH, J = 3.9, 13.5 Hz), 4.25 (s, 5H, C5H5), 4.28 (m, 1H, C5H4), 4.31 (m, 1H, C5H4), 4.34 (m, 
1H, C5H4), 4.42 (m, 1H, C5H4), 4.88 (bs, 1H, NH), 4.93 (bs, 1H, NH), 5.17 (d, 1H, CH2=, J = 1.2 Hz), 
5.31 (d, 1H, CH2=, J = 1.2 Hz); 
13C-NMR (D2O): 18.19 (CH3), 38.89, 112.34 (2CH2), 46.63 (CH), 
68.75 (C5H5), 65.91, 68.04, 68.15, 69.04 (C5H4), 76.87 (CipsoFc), 55.01, 158.75 (2C); MS: m/z 350 
[M]
+. Anal. Calcd. for C16H19FeKN2O: C 54.88, H 5.47, N 7.99. Found: C 55.01, H 5.36, N 8.05.%. 
3.3. Reactions of 3-Ferrocenylmethylidene-pentane-2,4-dione (1) with p-Aminobenzamidine 
Dihydrochloride (3) 
Following the general procedure, the reaction of 1 (1.48 g, 5.0 mmol) with p-aminobenzamidine 
dihydrochloride (3, 2.07 g, 10.0 mmol) in a mixture of ethanol (60 mL) and H2O (10 mL) in the 
presence of K2CO3 (3.0 g) for 2 h at 80 °C afforded compounds 4 and 8–11. 
2-(4-Aminophenyl)-4-ferrocenyl-6-methylpyrimidine ( 8). Orange crystals, yield 0.44 g (24%), m.p. 
153–154 °C. IR (KBr): 483, 545, 593, 771, 824, 840, 1001, 1023, 1104, 1176, 1254, 1303, 1325, 1376, Molecules 2014, 19  51 
 
1438, 1489, 1522, 1570, 1585, 1621, 1725, 2854, 2924, 3082, 3096, 3210, 3364, 3459 cm
−1; 
1H-NMR: 
2.53 (s, 3H, CH3), 3.90 (bs, 2H, NH2), 4.07 (s, 5H, C5H5), 4.47 (m, 2H, C5H4), 5.05 (m, 2H, C5H4), 
6.77 (d, 2H, C6H4, J = 8.7 Hz), 6. 97 (s, 1H, CH=), 8.36 (d, 2H, C6H4, J = 8.7 Hz); 
13C-NMR: 24.56 
(CH3), 70.01 (C5H5), 68.09, 70.77 (C5H4), 81.52 (CipsoFc), 112.69 (CH=), 114.72, 129.88 (C6H4), 
128.87, 148.70, 163.99, 165.97, 167.16 (5C); MS: m/z 369 [M]
+. Anal. Calcd. for C21H19FeN3: C 
68.31, H 5.19, N 11.38. Found: C 68.32, H 5.17, N 11.26. 
3-Ferrocenyl-5-methyl-2-azaspiro[5.5]undeca-2,4,7,10-tetraen-1,9-dione ( 9). Orange crystals, yield 
0.22 g (12%), 176–178 °C. IR (KBr): 498, 681, 812, 835, 1002, 1026, 1039, 1105, 1196, 1206, 1226, 
1280, 1301, 1344, 1394, 1441, 1469, 1519, 1547, 1575, 1599, 1622, 1698, 1705, 2949, 3197, 3210, 
3345 cm
−1; 
1H-NMR: 2.13 (s, 3H, CH3), 4.21 (s, 5H, C5H5), 4.25 (m, 2H, C5H4), 4.39 (m, 2H, C5H4), 
6.71 (d, 2H, C6H4, J = 8.7 Hz), 7. 41 (s, 1H, CH=), 7.52 (d, 2H, C6H4, J = 8.7 Hz); 
13C-NMR: 29.64 
(CH3), 69.18 (C5H5), 68.87, 69.96 (C5H4), 89.71 (CipsoFc), 113.11 (CH=), 121.42, 131.33 (C6H4), 
48.31, 58.45, 132.21 , 154.34, 154.89 (5C); MS: m/z 371 [M]
+. Anal. Calcd. for C21H17FeNO2: C 
67.94, H 4.62, N 3.77. Found: C 68.03, H 4.75, N 3.69. 
1-Amino-3-ferrocenyl-5-hydroxy-5-methyl-2-azaspiro[5.5]undeca-1,3,7,10-tetraen-9-one (10). Orange 
crystals, yield 0.25 g (13%), m.p. 181–182 °C. IR (KBr): 486, 559, 725, 822, 842, 998, 1001, 1043, 
1109, 1197, 1231, 1256, 1273, 1328, 1379, 1445, 1520, 1557, 1595, 1608, 1646, 1684, 1725, 2967, 
3091, 3208, 3352, 3461 cm
−1; 
1H-NMR: 1.98 (s, 3H, CH3), 2.48 (bs, 1H, OH), 4.23 (s, 5H, C5H5), 4.17 
(m, 2H, C5H4), 4.27 (m, 2H, C5H4), 5.03 – 5.23 (bs, 2H, NH2), 6.22 (s, 1H, CH=), 6.65 (d, 2H, C6H4,  
J = 7.8 Hz), 7.55 (d, 2H, C6H4, J = 7.8 Hz); 
13C-NMR: 18.96 (CH3), 68.58 (C5H5), 66.02, 66.77, 67.90, 
68.21 (C5H4), 90.93 (CipsoFc), 103.89 (CH=), 112.95, 130.21 (C6H4), 47.28, 59.01, 130.19 , 153.11, 
153.56 (5C); MS: m/z 388 [M]
+. Anal. Calcd. for C21H20FeN2O2: C 64.97, H 5.19, N 7.21. Found: C 
64.84, H 5.23, N 7.30. 
Potassium 6-ferrocenyl-4-methyl-2-(4-oxo-2,5-cyclohexadienyliden)-4-hexahydropyrimidoxide ( 11). 
Yellow powder, yield 0.39 g (18%), m.p. dec.ca 298 °C. IR (KBr): 486, 553, 612, 715, 819, 913, 1000, 
1026, 1078, 1102, 1201, 1272, 1337, 1421, 1432, 1478, 1557, 1631, 1689, 1714, 2861, 2929, 3046,   
3323 cm
−1; 
1H-NMR: 1.85 (s, 3H, CH3), 2.09 (t, 1H, CH2, J = 13.2 Hz), 2.56 (dd, 1H, CH2, J = 4.2, 
13.2 Hz), 4.83 (dd, 1H, CH, J = 4.2, 13.2 Hz), 4.23 (s, 5H, C5H5), 4.24 (m, 2H, C5H4), 4.45 (m, 2H, 
C5H4), 5.98 - 6.05 (bs, 2H, 2NH), 6.64 (d, 2H, C6H4, J = 8.7 Hz), 7.39 (d, 2H, C6H4, J = 8.7 Hz);  
13C-NMR: 19.01 (CH3), 46.17 (CH2), 50.07 (CH), 68.68 (C5H5), 66.05, 67.85, 68.03, 69.40 (C5H4), 
85.13 (CipsoFc), 112.62, 130.11 (C6H4), 55.03, 130.88, 142.12, 167.51 (4C); MS: m/z 388 [M]
+. Anal. 
Calcd. for C21H21FeKN2O2: C 58.76, H4.93, N 6.53. Found: C 58.87, H 5.01, N 6.42. 
3.4. Crystal Structures of 6, 7 and 8 
Single crystals of 6 and 8 were obtained by crystallization from CH2Cl2, while crystals of 7 were 
obtained by crystallization from H2O. The unit cell parameters and the X-ray diffraction intensities of 
6,  7 and 8 were recorded on a Gemini (detector Atlas CCD, Cryojet N2) diffractometer. The 
crystallographic data, the parameters of the X-ray diffraction experiments, and refinements are listed in Molecules 2014, 19  52 
 
supplementary Table S2. The structure of compounds 6–8 were solved by the direct method   
(SHELXS-97 [22]) and refined using full-matrix least-squares on F
2. 
Crystal data for C16H19FeNO2 ( 6): M = 313.17 g·mol
−1, orthorhombic P b c a, a = 10.5206(6),   
b = 10.1711(5), c = 25.8276(12) Å,  = 90, β = 90,  = 90°, V = 2763.7(2) Å
3, T = 130(2) K, Z = 8,  
ρ = 1.505 Mg/m
3, wavelength 0.71073 Å, F(000) = 1312, absorption coefficient 1.091 mm
−1, scan range 
3.66 ≤ θ ≤ 26.05°, 2713 independent reflections, Rint = 0.0663, 20243 total reflections, 188 refinable 
parameters, final R indices [I > 2σ(I)] R1 = 0.0343, wR2 = 0.0677, R indices (all data) R1 = 0.0558,  
wR2 = 0.0763, goodness-of-fit on F
2 1.087, largest difference peak and hole 0.333/−0.318 eÅ
−3. 
Crystal data for C32H38Fe2K2N4O2  (7): M = 700.56 g·mol
−1, monoclinic P21/c, a = 10.5530(5),   
b = 9.8630(5), c = 15.1210(7) Å,  = 90, β = 101.702(5),  = 90°, V = 1541.15(13) Å
3, T = 130(2) K, 
Z = 2, ρ = 1.510 Mg/m
3, wavelength 0.71073 Å, F(000) = 728, absorption coefficient 1.248 mm
−1, scan 
range 3.34 ≤ θ ≤ 26.13°, 3041 independent reflections, Rint = 0.0830, 11105 total reflections, 199 refinable 
parameters, final R indices [I > 2σ(I)] R1 = 0.0555, wR2 = 0.1266, R indices (all data) R1 = 0.0993,  
wR2 = 0.1357, goodness-of-fit on F
2 1.008, largest difference peak and hole 0.814/−0.789 eÅ
−3. 
Crystal data for C21H19FeN3 (8): M = 369.24 g·mol
−1, monoclinic P21/c, a = 11.0190(5), b = 14.3412(5),  
c = 12.1698(4) Å,  = 90, β = 101.661(4),  = 90°, V = 1883.45(12) Å
3, T = 293(2) K, Z = 4,  
ρ = 1.302 Mg/m
3, wavelength 1.54180 Å, F(000) = 768, absorption coefficient 6.460 mm
−1, scan range 
4.10 ≤ θ ≤ 66.59°, 3317 independent reflections, Rint = 0.0839, 11651 total reflections, 233 refinable 
parameters, final R indices [I > 2σ(I)] R1 = 0.0431, wR2 = 0.1652, R indices (all data) R1 = 0.0768, 
wR2 = 0.1779, goodness-of-fit on F
2 0.979, largest difference peak and hole 1.419/−0.539 eÅ
−3. 
CCDC-927702 (for 6), CCDC-927704 (for 7) and CCDC-927703 (for 8) contain the supplementary 
crystallographic data for this paper. This data can be obtained free of charge at 
www.ccdc.cam.ac.uk/const/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12, 
Union Road, Cambridge DB2 1EZ, UK; Fax: (internat.) +44 1223/336 033; E-mail: 
deposit@ccdc.cam.ac.uk]. 
4. Conclusions 
Thus, it has been found that the two tautomeric forms (amidoimine and ene-1,1-diamine) of 
acetamidine (2) and p-aminobenzamidine (3) react with 3-ferrocenylmethylidene-2,4-pentanedione (1). 
Such an observation has been made for the first time. Two processes take place during the reaction: 
fragmentation of β-diketone  1 into β-ferrocenylvinyl(methyl)ketone  4 and three-component 
cyclocondensation–fragmentation, which leads to simultaneous formation of mixtures of 
ferrocenylpyrimidine and piperidone derivatives 5–11, including spiro compounds (9,  10), and 
polymeric coordination compounds: potassium hexahydropyrimidoxides (7, 11). The results are so 
unexpected that they surely deserve more detailed investigation using a broader spectrum of reagents, 
in order to have more opportunities for practical studies of such processes. Synthesis of stable 
polymeric complexes of alkaline metals and studies of their physicochemical, biological, etc. 
properties are of special interest.  Molecules 2014, 19  53 
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